IgGenix is a California-based pre-clinical biotechnology company that researches and develops novel antibody therapies for the treatment of allergic diseases.
Business Model:
Revenue: $2.5M
Employees: 11-50
Address: 681 Gateway Blvd.
City: San Francisco
State: CA
Zip: 94080
Country: US
IgGenix is a California-based pre-clinical biotechnology company that researches and develops novel antibody therapies for the treatment of allergic diseases.
Contact Phone:
+16504919626
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2023 | Series B | $0 |
Eli Lilly Eli Lilly Eli Lilly Eli Lilly |
8/2020 | Series A | 2 | $10M |
Khosla Ventures Parker Ventures Khosla Ventures Parker Ventures |
7/2021 | Series A | $0 |
Alexandria Venture Investments AllerFund Khosla Ventures Mattias Westman Shangbay Capital Alexandria Venture Investments AllerFund Khosla Ventures Mattias Westman Shangbay Capital |
2/2023 | Series B | $40M |
Eli Lilly and Company Khosla Ventures AllerFund |
4/2022 | Series A | 1 | - |
Global Brain Corporation Global Brain Corporation |
7/2021 | Series A | 5 | $25M |
Khosla Ventures Alexandria Venture Investments ShangBay Capital AllerFund Alexandria Venture Investments AllerFund Khosla Ventures Mattias Westman Shangbay Capital |
4/2022 | Series A | 1 | - |
Global Brain Corporation Global Brain Corporation |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|